
Avinger Inc (NASDAQ:AVGR) Gets CE Marking Nod For In-Stent Restenosis Treatment Indication
Avinger Inc (NASDAQ:AVGR) a key developer of unique treatments for Peripheral Artery Disease reported Conformité Européenne Marking approval for curing in-stent restenosis using the Pantheris®













